About this trial
RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future.
PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
pancreas adenocarcinoma
islet cell cancer
pancreatic cysts
pancreatitis (hereditary, acute, or chronic)
Disqualifiers
Under the age of 18
Unable to provide informed consent
Prison inmates
Trial population
Patients with known or suspected pancreas disease including pancreas adenocarcinoma, islet cell cancer, pancreatic cysts, pancreatitis (hereditary, acute, or chronic) or the next of kin of deceased participants.
Trial design
Case-only
Prospective
Treatments tested in this trial
medical chart review
Other interventionbaseline, 12 month and 36 months
survey administration
Other interventionbaseline, 6 month, 12 month
biospecimen collection
Other interventionbaseline
Treatment groups
Trial outcomes
Primary outcomes
Collection of clinical data, health and family histories by survey
Collection of blood and/or tissue, fecal and oral specimens
Collection of information regarding food preparation and intake by survey
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Mayo Clinic
Lead sponsor
National Cancer Institute (NCI)
Collaborator